Hospira Down 6.9% On Earnings Miss (HSP)

Shares of Lake Forest, Illinois-based Hospira Inc. HSP are trading down 6.9% at $51.28 per share during the Wednesday afternoon trading session. The day's trading range for shares of Hospira Inc has been between $49.51 and $51.48 per share. Analysts covering the company's stock give it a consensus price target of $65.62 per share. Volume of 9.1 million shares is already 9 times the daily average volume of 1 million shares. Hospira Inc. (HSP) announced on Wednesday morning that it failed to meet consensus Wall Street expectations. Hospira Inc announced 4th quarter adjusted earnings per share of 77 cents, on revenue of $992 million. According to a survey of analysts by Thomson Reuters, the average Wall Street estimate called for earnings of 93 cents per share, on revenue of $1.04 billion. Hospira Inc is the world leader in specialty generic injectable pharmaceuticals, offering one of the broadest portfolios of generic acute-care and oncology injectables, as well as integrated infusion therapy and medication management solutions Read more from Benzinga's Company news.